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Have we made progress in identifying (surgical) innovation? 
 
Earl (2019) correctly signals the ambiguous nature of innovation as a specific category of healthcare 
activity. His own definition – innovative practice is that which deviates from an idealised expert-
consensus standard of care, which is based on evidence, experience and judgment – works 
adequately for the purposes of his argument. Yet identifying what is, and is not, innovation remains 
a very messy problem. 
Our research focuses on surgical practice, which is often held to be the site of continual, significant 
‘innovation’. Some of these innovations (like endovascular techniques in neurosurgery) prove 
successful. Others (like power morcellation of uterine fibroids) have been abandoned for causing 
serious harm. Surgical innovation appears lightly regulated, and surgeons apparently have discretion 
over when, where and why to innovate. This freedom brings serious challenges – for example, 
conflicts of interest may challenge surgeons’ abilities to offer patients, both vulnerable and trusting, 
unbiased advice. Preventing the premature adoption of innovations is difficult and, once adoption is 
widespread, risks harming patients and wasting resources should unanticipated risk-benefit profiles 
emerge. A balanced picture of effectiveness may only be discovered in large trials, which may 
happen too late, or not at all. These problems arise due to historical deficiencies in the rigor of 
surgical research, magnified by the effects of the learning curve. Regulation and oversight is 
particularly challenging because of difficulties in identifying what does, and does not, count as 
‘surgical innovation’. 
Identifying surgical innovation is complex. Some apparent innovations might not, on balance, be 
innovative. The profusion of ‘me-too’ devices that essentially duplicate existing innovations means 
that not all ‘new’ devices are innovative, and some may not require laborious appraisal. ‘Standard’ 
surgical procedures are frequently modified to take account of variations in patient anatomy. For the 
most part, these modifications constitute ‘normal variations’, which would appear wrongly classified 
as ‘innovative’. However, a small minority of variations may involve changes significant enough to 
constitute innovation.  
Outside of formal research activity the systematic reporting of outcomes of innovations (especially 
deleterious ones) does not occur. Different techniques for performing standard procedures may 
develop locally, leading to potentially dramatic variations which may go unrecognised. Usually it is 
only when a new technique is established as in some sense ‘safe’ that case series of successful 
outcomes are reported – but without detailed description of false starts, failures and early lessons 
learned whilst the procedure was still evolving. Reporting only successes without detailing early 
development – including ideas that were tried and failed - puts patients at risk by (1) failing to 
prevent the repetition of mistakes, (2) failing to systemically capture evidence, and (3) giving the 
false impression to patients that ‘innovation’ will always be beneficial. 
To protect patient safety (and protect surgeons), the impact of innovations should be better 
identified, evaluated and reported. One way to achieve this entails rigorously reporting and 
monitoring unexpected adverse outcomes of innovation, ideally using generic standardised 
reporting measures. Yet this requires us first to be able to reliably identify surgical innovation. Some 
progress has been made toward this goal: for example a team at Macquarie University have 
published a tool and definition to help surgeons identify innovation in their own practice (Hutchison 
et al. 2015). Meanwhile, by focusing on the process of innovation, rather than definition, the IDEAL 
framework has sought to identify stages of innovation that can be married with regulatory and 
ethical responses (Hirst et al. 2019). 
A recent conceptual study has concluded that the defining feature of innovation is ‘newness’ 
(Hutchison et al. 2015). Based on empirical work showing differences between what surgeons 
themselves consider to be innovation (Rogers et al. 2014), these researchers have concluded that a 
significant problem is that surgeons need help to identify innovation in their own practice, and have 
produced (and are testing) a tool to facilitate this. The tool identifies several ways in which a 
procedure or device could be innovative by being entirely new, new to an anatomical location or 
new to a patient group.  
This is a major advance on previous, ad hoc, definitions of innovation, and we agree that ‘newness’ is 
an important element of innovation. Yet, we are concerned that, despite including examples of 
absolute, anatomical and patient group ‘newness’ aimed at guiding surgeon’s assessments, 
‘newness’ is too subjective to reliably identify innovation. Because surgery will be composed of basic 
techniques (e.g. dissection), which are not themselves new, the newness of any innovation will be 
debatable. Additional qualifiers may be needed. For example, the economist Joseph Schumpeter 
defined innovation not as “new” but as “new combinations” in his seminal economic theory 
(Schumpeter 1949). Without such a qualifier, new procedures could always – rightly or wrongly – be 
classified as modifications to established procedures rather than as ‘new’. Furthermore, a definition 
of surgical innovation that is based on types of newness invites false positives and requires 
specificity, which passes the burden of identifying innovation using ‘newness’ to the surgeon. Yet it 
is questionable whether surgeons are always the most appropriate people to judge whether 
innovation is occurring, as they may have conflicts of interest in this regard (Rogers and Johnson 
2013). Effective oversight of surgical practice can only be achieved if we have ways to identify 
innovation that are independent of surgeons’ own judgements. 
Because surgical innovation is unlikely to involve a single discrete development, a model of the 
process by which surgical innovation develops is important. Such a model has been developed in the 
IDEAL framework (Hirst et al. 2019), based on the ‘classical’ model adopted in agricultural sociology 
and popularised by Everett Rogers (2003). This model suggests that the spread of surgical innovation 
has a clearly defined beginning and end, and follows the ‘S’ shaped curve of cumulative normal 
distribution. Yet, the development of complex innovations is often chaotic, with imprecise start- and 
end- points. In an agricultural context, Fliegel (1993) noted that, while this model works well on 
innovations like new seed corn varieties, where the innovation is a distinct and indivisible product, it 
struggles with technologies made up of multiple related components. Using patents and publications 
as proxies for innovation, it has been claimed that fields of surgical innovation do broadly map onto 
an ‘S’ shape (Hughes-Hallett et al. 2014). Yet, the study that makes this claim also shows that patents 
and publications continue, albeit in diminished quantities, in mature technologies, where innovative 
fields had apparently stabilised. This suggests refinements and (further) innovations continue at a 
low level even when innovative fields are mature. We infer that surgical innovations may have 
indistinct borders between invention, adoption and diffusion, and improvements to current models 
of the process of surgical innovation may also be needed. 
Despite advances in our understanding of innovation, much work remains. Without an empirically 
grounded understanding of what innovation is, and how and why innovation occurs in practice, 
ethical studies of the type Earl (2019) offers remain speculative. In our own research (Birchley et al. 
Accepted subject to revision), we mapped the way innovation was discussed and described in 72 
academic sources and discovered a vast array of properties and facets, which we could broadly 
categorise into five conceptual areas. These were the drivers, context and consequences of 
innovation, the ways to differentiate innovation from ‘normal’ practice or research, and the identity 
of the innovator. Taken as a whole they signalled that innovation is a messy concept. We felt 
innovation did not represent a natural kind that was amenable to simple classification or discrete 
study. This leads us to propose an eliminativist approach. The word ‘innovation’ has a rhetorical 
flourish, but that rhetorical flourish makes it problematic. It is a truly ‘rich’ concept – both 
descriptive and evaluative – which, though agreeably flexible, is imprecise and susceptible to 
manipulation and equivocation.  We therefore suggest that, for the purposes of serious study and 
for regulation, it should be avoided. Instead, we should closely consider what it is we are talking 
about and why, and spell that out precisely. In our case, our explicit focus is on ensuring the safe 
translation of surgical innovation into clinical practice; on procedures and devices which lack 
reported knowledge that can inform an assessment of their efficacy, effectiveness or safety. This, 
then, rather than trying to identify ‘innovation’, has formed the basis for our ongoing work. 
In summary, recent studies have further elucidated surgeons’ understandings of innovation, devised 
models of the process of innovation and developed a definition of innovation that has informed the 
first usable tool for surgeons to self-identify innovation. Yet, when attempting to clarify precisely 
what (surgical) innovation is, the profusion of possible understandings mean that the term itself is 
unhelpful. Thinking carefully about what we mean when we use the word ‘innovation’, and choosing 
to talk in those terms rather than about ‘innovation’, should avoid researchers talking at cross 
purposes and prevent the conceptual clutter around innovation from masking poor practice. Indeed, 
re-focusing in this way should allow us to continue to make progress on what really matters – such 
as, as Earl suggests, the ethical appropriateness of the procedure, however it is labelled or 
conceptualised. 
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